Ramachandra Sumant 4
4 · Lyell Immunopharma, Inc. · Filed Mar 25, 2025
Insider Transaction Report
Form 4
Ramachandra Sumant
Director
Transactions
- Purchase
Common Stock
2025-03-21$0.58/sh+200,000$115,220→ 200,000 total(indirect: By Trust)
Footnotes (2)
- [F1]The price reported above reflects the weighted average price of the shares purchased. These shares were purchased in multiple transactions at prices ranging from $0.5487 to $0.5879, inclusive. Upon request from the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price within the range set forth in this range.
- [F2]Shares held by the Sumant Ramachandra Rev Trust DTD 01/24/12. The Reporting Person is grantor and trustee of the Sumant Ramachandra Rev Trust DTD 01/24/12.